Koopmans P P, Thien T, Gribnau F W
Br Med J (Clin Res Ed). 1984 Dec 1;289(6457):1492-4. doi: 10.1136/bmj.289.6457.1492.
In an open triple crossover study in 10 patients with mild to moderate essential hypertension the influence was investigated of adding indomethacin 50 mg, naproxen 250 mg, or sulindac 200 mg, each twice daily for four weeks, to diuretic treatment with hydrochlorothiazide 50 mg a day. After two weeks' treatment with indomethacin a slight increase in blood pressure was observed, whereas both sulindac and naproxen tended to enhance the antihypertensive effect of hydrochlorothiazide. After treatment for four weeks, however, the effects of all three drugs on blood pressure appeared to be blunted. Furthermore, body weight increased significantly during treatment with indomethacin but not during treatment with naproxen or sulindac. No significant changes were found for various biochemical variables, including concentrations of plasma electrolytes and serum creatinine and albumin, plasma renin activity, plasma aldosterone concentration, and 24 hour urinary excretion of sodium and potassium, with the exception, however, of an increase in plasma potassium concentration during treatment with indomethacin. These observations suggest that the interaction of indomethacin, naproxen, and sulindac with diuretic treatment in mild to moderate essential hypertension is transient and of minor clinical importance.
在一项针对10例轻至中度原发性高血压患者的开放性三联交叉研究中,研究了每日添加50毫克消炎痛、250毫克萘普生或200毫克舒林酸(均每日两次,持续四周)至每日50毫克氢氯噻嗪利尿治疗的影响。使用消炎痛治疗两周后,观察到血压略有升高,而舒林酸和萘普生均倾向于增强氢氯噻嗪的降压效果。然而,治疗四周后,这三种药物对血压的影响似乎减弱。此外,使用消炎痛治疗期间体重显著增加,而使用萘普生或舒林酸治疗期间体重未增加。各种生化指标,包括血浆电解质、血清肌酐和白蛋白浓度、血浆肾素活性、血浆醛固酮浓度以及钠和钾的24小时尿排泄量,均未发现显著变化,但使用消炎痛治疗期间血浆钾浓度有所升高。这些观察结果表明,消炎痛、萘普生和舒林酸与轻至中度原发性高血压利尿治疗的相互作用是短暂的,临床意义不大。